Italian Medicines Agency Agenzia Italiana del Farmaco

Press releases

Comunicati Stampa

In questa sezione sono disponibili i comunicati stampa dell’Agenzia Italiana del Farmaco.

Asset Publisher

13/10/2021 - AIFA presents the Report “Medicines use in the elderly population in Italy”

The first Report "Medicines use in the elderly population in Italy", produced by the Medicines Utilisation Monitoring Centre (OsMed) with the coordination of the Italian Medicines Agency (AIFA) and the Istituto Superiore di Sanità (ISS) was presented at the Sala delle Colonne of the Angelicum ...

12/10/2021 - Ninth AIFA Report on the surveillance of COVID-19 vaccines

The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 September 2021 for the four vaccines used in the current vaccination campaign.

08/10/2021 - National Report "The use of medicines in the elderly population in Italy"

Produced by the National Observatory on the Use of Medicines (OsMed) with the coordination of AIFA and the Istituto Superiore di Sanità, the Report will be presented on Wednesday 13 October 2021 at 10.00

28/09/2021 - AIFA makes available the medicines anakinra, baricitinib and sarilumab for the treatment of COVID-19

Approved the inclusion in the list of Law 648/96, which allows to charge these medicines to the National Health Service.

22/09/2021 - COVID-19 vaccine: AIFA publishes list of main medicines with immunosuppressive activity

In order to select the subjects for whom the additional dose of COVID-19 vaccine may be indicated

17/09/2021 - AIFA confirms assessment of the benefit/risk profile for Zolgensma

The Italian Medicines Agency has sent a letter to the President of the Puglia Region, Michele Emiliano, on the case of the two children with SMA1 for whom the administration of Zolgensma therapy is requested

15/09/2021 - AIFA presented the first “Atlas of social inequalities in medicines use”

The aim of this new publication is to evaluate how access to medicines for the main chronic diseases is related to specific socio-economic factors

10/09/2021 - Eighth AIFA Report on the surveillance of COVID-19 vaccines

The Italian Medicines Agency has published its eighth Pharmacovigilance Report on COVID-19 Vaccines.

09/09/2021 - AIFA’s Scientific Technical Committee issues opinion on administering additional doses of COVID-19 vaccines

AIFA’s Scientific Technical Committee (CTS), at its meeting on 7-9 September 2021, expressed its opinion on the administration of additional doses of vaccine against COVID-19, answering the questions posed by the Ministry of Health.

20/08/2021 - AIFA denies fake news: authorisations for anti-COVID vaccines remain valid

AIFA strongly denies the totally false news according to which, after the authorisation by the Agency for the use of some monoclonal antibodies against COVID-19, the marketing authorisation for COVID vaccines issued by the EMA has been withdrawn.

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

ABC della Ricerca Clinica - Perché la randomizzazione è essenziale?

Go to YouTube channel

go to beginning of content